Collectively, these findings showed that USP8 stabilizes PD-L1 levels in pancreatic cancer cells by inhibiting the degradation of PD-L1 via the ubiquitin-proteasome pathway. This evidence concerns the gene USP8 and familial pancreatic carcinoma.